Page R L
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9047, USA.
Am Heart J. 1995 Oct;130(4):871-6. doi: 10.1016/0002-8703(95)90090-x.
The treatment of arrhythmias during pregnancy is complicated by concerns for fetal well-being. Although no drug is absolutely safe, most are well tolerated. Nonpharmacologic therapy includes vagal maneuvers and esophageal pacing. Temporary and permanent pacing have been used safely during pregnancy, as has direct current cardioversion. Cardiopulmonary resuscitation is complicated by concerns for the fetus, which may be viable at 25 weeks. Diagnosis of the cause of tachyarrhythmias may be enhanced by roving chest leads or esophageal recording. Both supraventricular and ventricular tachycardias may become manifest during pregnancy, and conservative management is desirable if the symptoms are mild. Supraventricular tachycardias respond acutely to adenosine. Ventricular arrhythmias during pregnancy often occur in the absence of structural heart disease and are responsive to drug therapy. The safe use of an implantable cardioverter-defibrillator has been described.
孕期心律失常的治疗因对胎儿健康的担忧而变得复杂。虽然没有哪种药物是绝对安全的,但大多数药物耐受性良好。非药物治疗包括迷走神经手法和食管起搏。孕期已安全使用临时和永久性起搏,直流电复律也是如此。心肺复苏因对胎儿的担忧而变得复杂,胎儿在25周时可能存活。游走性胸导联或食管记录可能有助于快速心律失常病因的诊断。室上性和室性心动过速在孕期均可能出现,症状较轻时宜采用保守治疗。室上性心动过速对腺苷急性起效。孕期室性心律失常常发生于无结构性心脏病的情况下,且对药物治疗有反应。已有关于可植入式心脏复律除颤器安全使用的报道。